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Abstract
Objective: Trinucleotide GGC repeat expansion in the 5’UTR of the
NOTCH2NLC gene has been recognized as the pathogenesis of neuronal
intranuclear inclusion disease (NIID). Previous studies have described that
some NIID patients showed clinical and pathological similarities with multiple
system atrophy (MSA). This study aimed to address the possibility that GGC
repeat expansion in NOTCH2NLC might be associated with some cases diagnosed as MSA. Methods: A total of 189 patients with probable or possible MSA
were recruited to screen for GGC repeat expansion in NOTCH2NLC by repeatprimed PCR (RP-PCR). In addition, long-read sequencing (LRS) was performed for all patients with RP-PCR-positive expansion, five patients with RPPCR-negative expansion, and five controls on the Nanopore platform. Skin
biopsies were performed on two patients with GGC expansion. Results: Five of
189 patients (2.6%) were found to have GGC expansion in NOTCH2NLC. LRS
results identified that the five patients had GGC expansion between 101 and
266, but five patients with RP-PCR-negative expansion and five controls had
GGC expansion between 8 and 29. Besides the typical symptoms and signs of
MSA, patients with GGC expansion might have longer disease duration, severe
urinary retention, and prominent cognitive impairment. In the skin samples
from the patients with GGC expansion, typical p62-postive but alpha-synuclein-negative intranuclear inclusions were found in fibroblasts, adipocyte and
ductal epithelial cells of sweat glands. Conclusion: Trinucleotide GGC repeat
expansion in NOTCH2NLC could be observed in patients with clinically diagnosed MSA. Adult-onset NIID should be considered as a differential diagnosis
of MSA.

Introduction
Recently trinucleotide GGC repeat expansion in the 50 untranslated region (50 UTR) of the NOTCH2NLC gene
has been recognized to be involved in the pathogenesis of
neuronal intranuclear inclusion disease (NIID).1-4 The
neurological manifestations of adult-onset NIID have a
high degree of clinical heterogeneity, and usually include
autonomic dysfunctions, parkinsonism, cerebellar ataxia,
cognitive impairments, encephalitic episode, pyramidal
signs, and sensory disturbances.5 Neuropathological

examination of NIID patients has demonstrated the widespread presence of eosinophilic intranuclear inclusions in
the cells of central and peripheral nervous systems as well
as other organs.6
Multiple system atrophy (MSA) is a deteriorating neurodegenerative disorder pathologically characterized by
alpha-synuclein-positive glial cytoplasmic inclusions in
multiple brain areas.7 Clinical features of MSA mainly
comprise dysautonomia, parkinsonism, cerebellar ataxia,
and pyramidal signs in various combinations.8 Regarding
clinical presentation, MSA appears to be autonomic
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failure with parkinsonism (MSA-P), cerebellar ataxia
(MSA-C), or both.9 Previous studies have described that
some NIID patients showed clinical and pathological similarities with those of MSA.10,11 Therefore, adult-onset
NIID appears to be a possible phenocopy of MSA and
thus a potentially important differential diagnosis of
MSA. There is considerable uncertainty about the significance of this clinical overlap, especially given the possible
genetic implications of NIID and the poor prognosis of
MSA compared with NIID.12,13 To address these questions, we screened the NOTCH2NLC gene in 189 sporadic
patients with clinically diagnosed MSA and 325 healthy
adults with the aim of identifying the possible association
between MSA and GGC repeat expansion of the
NOTCH2NLC gene.

GACCTCCTCCGCCGCCGCCGCC-30 , and 0.3 lmol/L of
M13-linker-R: 50 -CAGGAAACAGCTATGACC-30 . After
incubation at 98°C for 10 min, the cycling conditions were
followed by: 16 cycles of 98°C for 30 sec, 66°C for 1 min
with reduced 0.5°C per cycle and 68°C for 8 min; then 32
cycles of 98°C for 30 sec, 58°C for 1 min, and 68°C for
8 min; then a final elongation step of 68°C for 10 min.
Electrophoresis was performed on a 3500xl Genetic analyzer (Thermo Fisher Scientific, Waltham, MA) and the
data were analyzed using GeneMapper software (Thermo
Fisher Scientific). A saw-tooth tail pattern in the electropherogram was considered to be the disease-associated
repeat expansion.

Materials and Methods

In order to precisely calculate and verify the number of
GGC repeat, long-read sequencing (LRS) was performed
on all patients with RP-PCR-positive GGC repeat expansion, five patients with RP-PCR-negative GGC repeat
expansion, and five control subjects through the Oxford
Nanopore platform. Large insert-size libraries were created according to the manufacturer’s protocol (Oxford
Nanopore, UK). Mapping-based methods were used for
regular structural variation calling and repeatHMM algorithm was applied for counting GGC motifs in the short
tandem repeat region (STR) in the NOTCH2NLC gene.

Subjects
One hundred eighty-nine patients with sporadic MSA visiting in any of the three academic neurological centers
between July 2015 and July 2019 were retrospectively
recruited for this study. The inclusion criteria included:
(1) probable or possible MSA;9 (2) no family history of
MSA and other neurological disorders; and (3) DNA
samples available. MSA patients were identified from
searching the electronic medical record using International Classification of Diseases, tenth Revision (ICD10)
code G90.302. Clinical information, including gender,
age, age of onset, progression of disease, family history,
and other clinical manifestations, was collected. A battery
of laboratory tests was conducted to exclude metabolic,
toxic, and inflammatory causes. A total of 325 Chinese
healthy adults matched for gender, age, and residence
areas were also recruited as the control group. All the
control subjects were examined by neurologists to rule
out neurological disorders. All patients’ samples were
obtained after a written consent signed by each individual
in compliance with the bioethics laws of China, as well as
the Declaration of Helsinki. The research was approved
by the ethics committee of the first affiliated hospital of
Nanchang university.

Nanopore long-read sequencing

Pathological examinations of skin biopsy
Open skin biopsies from the distal part of the right leg
(10 cm above the external malleous) were performed in
two MSA patients (patient 1 and patient 4) with GGC
repeat expansions of the NOTCH2NLC gene. A part of
the specimen was fixed by 4% formalin solution, embedded in paraffin, cut into 4-mm-thick sections, and stained
with hematoxylin and eosin (HE). The immunohistochemical stains were performed with anti-p62 antibody
(ab56416, Abcam) and alpha-synuclein (ab27766,
Abcam). For electron microscopy, a part of specimens
was initially fixed in 2.5% glutaraldehyde, subsequently
fixed in 1% osmium tetroxide, and embedded in Epon
812. Ultrathin sections were examined through electron
microscope (JEOL-1230, Japan).

Repeat-primed PCR
The repeat-primed PCR (RP-PCR) was initially used to
identify the repeat expansion in the NOTCH2NLC gene.
RP-PCR was performed as described in our previous
study.4 In brief, the PCR primer mix contained three
primers: 0.3 lmol/L of NOTCH2NLC-F: 50 -FAMGGCATTTGCGCCTGTGCTTCGGACCGT-30 , 0.15 lmol/
L of M13-(GGC)4(GGA)2-R: 50 -CAGGAAACAGCTAT
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Results
GGC expansion in sporadic MSA
Among 189 patients with Gilman-criteria MSA, we identified five patients (2.6%) with GGC repeat expansion in
the NOTCH2NLC gene. The long saw-tooth curves indicated that the number of GGC in the five patients did
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Figure 1. Repeat-primed PCR was used to identify the repeat expansion in the NOTCH2NLC gene. The long saw-tooth curves indicated that the
numbers of GGC in the five patients did exceed a value of at least 100 repeat expansions, A to E stand for patient 1 to patient 5, respectively.
The sequencing map showed a single peak wave without saw-tooth pattern in a healthy control subject (F).

Figure 2. Nanopore long-read sequencing (LRS) verified the GGC repeat expansion of NOTCH2NLC. LRS revealed 12 reads of repeats between
18 and 24, and 7 reads of repeats between 112 and 138 in patient 1(A). LRS showed 14 reads of repeats between 11 and 16, and 7 reads of
repeats between 140 and 155 in patient 2 (B). LRS exhibited 21 reads of repeats between 22 and 28, and 6 reads of repeats between 118 and
135 in patient 3 (C). LRS identified 11 reads of repeats between 12 and 16, and 10 reads of repeats between 101 and 126 in patient 4 (D). LRS
found 26 reads of repeats between 9 and 23, and 5 reads of repeats between 210 and 266 in patient 5 (E). LRS only showed 21 reads of repeats
between 18 and 26 in a control (F).
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exceed a value of at least 100 repeat expansions, although
our method could not determine the precise number of
GGC repeat expansion (Fig. 1A–E). Among the 325
healthy control subjects, the sequencing map showed a
single peak wave without saw-tooth pattern (Fig. 1F).
To confirm the RP-PCR results and quantify the number of repeat expansion, we performed low-coverage longread genome sequencing. The repeatHMM algorithm was
used to count GGC repeats in the STR region of the
NOTCH2NLC gene. In patient 1, 19 reads of GGC repeats
were found in the STR of the NOTCH2NLC gene with 12
reads of repeats between 18 and 24, as well as 7 reads of
repeats between 112 and 138 (Fig. 2A). In patient 2,
repeatHMM identified 21 reads of GGC repeats, including
14 reads of repeats between 11 and 16, and 7 reads of
repeats between 140 and 155 (Fig. 2B). In patient 3, 27
reads of GGC repeats were identified, including 21 reads of
repeats between 22 and 28, and 6 reads of repeats between
118 and 135 (Fig. 2C). In patient 4, 21 reads of GGC
repeats were found, including 11 reads of repeats between
12 and 16, and 10 reads of repeats between 101 and 126
(Fig. 2D). In patient 5, repeatHMM identified 31 reads of
GGC repeats, including 26 reads of repeats between 9 and
23, and 5 reads of repeats between 210 and 266 (Fig. 2E).

In five patients with RP-PCR-negative GGC expansion and
five control subjects, repeatHMM indicated GGC repeats
ranging between 8 and 29 (Fig. 2F).

Clinical features of patients with GGC
expansion
A total of 189 patients including 101 males and 88
females were recruited in the study. The median age of
disease onset was 54 years (interquartile range between
47.5 and 56.5). The median duration of disease at entry
was 3 years (interquartile range between 1 and 4.5). Onset
of either motor symptoms or dysautonomia was defined
as the disease onset. According to the 2008 consensus criteria, 133 (70.4%) patients were diagnosed with probable
MSA and 56 (29.6%) patients were diagnosed with possible MSA. Among the 133 patients with probable MSA, 92
(69.2%) patients were classified as MSA-C and 41
(30.8%) as MSA-P. Among the 56 patients with possible
MSA, 26 (46.4%) patients were classified as MSA-C and
19 (33.9%) as MSA-P; 11 (19.7%) could not be categorized into either MSA-C or MSA-P.
Five patients with GGC repeat expansion comprised
three women and two men (Table 1). The median age of

Table 1. The clinical features of five MSA patients with GGC repeat expansion in the NOTCH2NLC gene
Variables
Clinical
Age(y)/gender
Disease duration (y)
Orthostatic hypotension
Bladder dysfunction
Cerebellar ataxia
Parkinsonism
Pyramidal signs
Stridor
Constipation
Tremor
Cognitive impairment
Muscle weakness
Visual loss
Radiological
Cerebellar atrophy
Putamen hyperintensity
Hot cross bun sign
MCP atrophy
Cerebellar WML
Cerebral WML
Corticomedullary DWI
GGC repeats range
MSA diagnosis
MSA subgroup

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

61/F
9
+
+

+
+

+
+
+

+

55/F
11

+



+
+
+
+



57/M
6
+
+
+

+



+
+


66/F
8
+
+
+




+
+



49/M
3
+
+

+
+








+



+

112–138
probable
MSA-P

+






140–155
possible
MSA-C

+

+
+
+
+

118–135
probable
MSA-C

+


+
+
+
+
101–126
probable
MSA-C






+

210–266
probable
MSA-P

WML, white matter lesion; DWI, diffused weighted image; MCP, middle cerebellar peduncle; MSA-C, MSA with predominantly cerebellar ataxia;
MSA-P, MSA with predominantly parkinsonism.
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onset was 57 years (interquartile range between 55 and
61) and disease duration at entry was 8 years (interquartile range between 6 and 9). All of them initially presented with prominent urinary dysfunction (four with
urinary retention and one with urinary incontinence).
According to the 2008 consensus criteria, patient 1 was a
probable MSA-P characterized by orthostatic hypotension,
urinary incontinence, poorly levodopa-responsive parkinsonism, and pyramidal signs; patient 2 was a possible
MSA-C characterized by urinary retention, gait ataxia,
tremor, and stridor; patient 3 was a probable MSA-C
characterized by orthostatic hypotension, urinary retention, cerebellar ataxia, and pyramidal signs; patient 4 was
a probable MSA-C characterized by orthostatic hypotension, urinary retention, and cerebellar ataxia; and patient
5 was a probable MSA-P characterized by orthostatic

hypotension, urinary retention, and poorly levodopa-responsive parkinsonism. A comparison of clinical features
between patients with GGC repeat expansion and those
without GGC repeat expansion was presented in Table 2.
The statistical tests in Table 2 were nonparametric; and
the results were exploratory, and were not corrected for
multiple comparisons.
Magnetic resonance imaging (MRI) was conducted in
all patients, but 91 (48.1%) patients were performed on a
1.5T scanner. Cerebellar atrophy in different degree was
identified in 141 patients, and hot cross bun sign was
indicated in 42 patients without GGC expansion
(Fig. 3A–C). Basal ganglia changes such as putamen atrophy or lineal T2 high intensity of the lateral margin of
the putamen were observed in 38 patients without GGC
expansion (Fig. 3D–F). In addition, 53 of 184 patients
without GGC expansion exhibited periventricular white
matter hyperintensities in different degree possibly suggesting chronic ischemic arteriopathy (Fig. 3G–I). In contrast, four of five patients with GGC repeated expansion
showed cerebral white matter lesion (Fig. 3J–L).

Table 2. Comparison of demographic and clinical characteristics
between MSA patients with and without GGC repeat expansion.

Variables
Gender
(male)
Age (years)
Disease
duration
(years)
Parkinsonism
Ataxia
Bladder
dysfunction
Orthostatic
hypotension
Constipation
Pyramidal
signs
Cognitive
impairments
Cerebral
WML
Cerebellar
abnormality
Hot cross
bun sign
MSA-P
MSA-C
Probable
MSA
Possible MSA

Patients with GGC
repeat expansion
(n = 5)
2 (40.0%)
57 (55, 61)
8 (6,9)

Patients without GGC
repeat expansion
(n = 184)

P
value*

Skin pathological changes

99 (53.8%)

0.665

54 (47.5, 56.5)
3 (1, 4.5)

0.896
0.045*

2 (40.0%)
3 (60.0%)
5 (100.0%)

115 (62.5%)
157 (85.3%)
151 (82.1%)

0.371
0.169
0.589

4 (80.0%4)

139 (75.5%)

1.000

2 (40.0%)
3 (60.0%)

88 (47.8%)
73 (39.7%)

1.000
0.393

4 (80.0%)

118 (62.4%)

0.657

Skin biopsy was performed on two of five MSA patients
with GGC repeat expansion. Intriguingly, their skin
biopsy samples contained typical eosinophilic intranuclear
inclusions in the fibroblasts, fat cells, and ductal epithelial
cells of sweat glands (Fig. 4A and B). These eosinophilic
inclusions in ductal epithelial cells of sweat glands
(Fig. 4C) and fat cells (Fig. 4D) were p62 positive, but
alpha-synuclein negative (Fig. 4E). Electron microscopy
revealed a pile of round-halo filamentous materials in the
center of the nucleus (Fig. 4F).

Discussion
4 (80.0%)

53 (34.2%)

0.030*

3 (60.0%)

139 (75.5%)

0.600

1 (20.0%)

41 (22.2%)

1.000

2 (40.0%)
3 (60.0%)
4 (80.0%)

58 (31.5%)
115 (62.5%)
129 (70.1%)

0.653
0.654
1.000

1 (20.0%)

55 (29.9%)

1.000

Variables are presented as n (%) in nominal data or median (IQR) in
continuous data. For between-group comparisons, using nonparametric rank sum test or Fisher exact test, as appropriate.
*Denotes a statistically significant difference bettween the two
groups, P < .05.

Because of the potential clinical overlap between MSA
and NIID,11,14 there has been considerable interest in the
possibility that the signs and symptoms of some MSA
patients may actually be due to GGC repeat expansion of
the NOTCH2NLC gene. In this study, we used a convenient RP-PCR to screen the 50 UTR of the NOTCH2NLC
gene, and found that 2.6% (5/189) of patients with clinically diagnosed MSA had GGC repeat expansions. The
results were verified in a part of patients by long-read
sequencing; nevertheless, the incidence would be more
convincing, if the repeat number of trinucleotide GGC
could be quantified in all subjects recruited in this study.
Familial clustering has been observed in a small number of patients with pathologically proven MSA,15,16
although MSA is classically considered as a sporadic disease, evenly a family history of parkinsonism or ataxia is
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defined as a nonsupporting feature in the current diagnostic criteria.9 Neurogeneticists have never given up the
hope of identifying potential pathogenic genes for MSA.
In 2013,17 genetic variants in the COQ2 gene were associated with familial MSA. The study additionally described
several rare variants that were associated with sporadic
MSA.17 However, the significance of these findings
remains unclear because several studies have not confirmed or only partly replicated the findings.18 For the
same reason, the association between MSA and trinucleotide expansion of NOTCH2NLC identified in this
study should also be interpreted with cautions, and more
studies should be investigated in other patients with clinically diagnosed or pathologically proven MSA.

NIID has been described as a heterogeneous disease
because of the variable phenotypes depending on the different patterns of central, peripheral, and autonomic nervous system involvement.6,19 Some patients with adultonset NIID presented with isolated urinary disturbance
at the early stage of disease, and gradually started showing parkinsonism, cerebellar ataxia, dementia, and pyramidal symptoms at the late stage of disease. Therefore,
the clinical features in these patients with adult-onset
NIID might mimic the phenotype of MSA.10,11 The five
MSA patients with GGC repeat expansion in
NOTCH2NLC had some clinical features that might be
useful to differentiate between patients with adult-onset
NIID and MSA.

Figure 3. Magnetic resonance imaging representative in this group of MSA patients. Cerebellar atrophy and hot cross bun sign were indicated in a
MSA-C patient without GGC expansion (A–C). Putamen atrophy and lineal T2 high intensity of the lateral margin of the putamen were observed in
a MSA-P patient without GGC expansion (D–F). White matter lesions (WML) suggesting chronic ischemic arteriopathy were notable in a MSA-C
patient without GGC expansion (G–I). White matter lesions and cortical atrophy were found in a MSA-C patient with GGC expansion (J–L).
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Figure 4. Skin biopsy of two MSA patients with GGC repeat expansion. HE stain revealed typical eosinophilic intranuclear inclusions in the nuclei
of fibroblasts and ductal epithelial cells of sweat glands (A). Magnification of the rectangle in A (B, arrow). These eosinophilic inclusions in
fibroblasts and ductal epithelial cells of sweat glands (C, arrow) and fat cells (D, arrow) were p62 positive, but alpha-synuclein negative (E).
Electron microscopy revealed a pile of round-halo filamentous materials in the center of the nucleus (F).

MSA is a relentlessly progressive neurodegenerative disorder with median survival from symptom onset of 6–
10 years.12,20 In this study, despite most patients with

NOTCH2NLC expansion fulfilled Gilman consensus criteria for probable rather than possible MSA, they progressed much more slowly than usual in MSA, and had
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relatively longer disease duration before diagnosis. Therefore, genetic screening of the NOTCH2NLC gene should
be recommended for MSA patients with long duration of
disease.
Dysautonomia is the most common feature in both
MSA and NIID.6,21 Patients with MSA usually present
with constipation, erectile dysfunction, urinary disturbance, and orthostatic hypotension,21 whereas patients
with adult-onset NIID more frequently exhibit bladder
dysfunction, miosis, intestinal paralysis, and orthostatic
hypotension.6 In this study, all five patients showed that
bladder dysfunctions were more prominent than other
autonomic impairments. In addition, urinary retention
was the most frequent urinary feature in these patients;
whereas urinary incontinence was documented less commonly. Recently, the long-term history of neurogenic urinary disturbance prior to other neurological symptoms
was emphasized in the diagnostic workflow for adult-onset NIID.22 Therefore, GGC repeat expansion of
NOTCH2NLC should be reminded in these MSA patients
with prominent urinary retention.
Although notable dementia is a nonsupporting feature
in the current diagnosis criteria for MSA, cognitive
impairment is increasingly recognized as a relevant symptom in MSA patients.9,21 Up to 90% of adult-onset NIID
patients are characterized by obviously progressive cognitive impairment.6 Our study revealed that patients with
repeat expansion in NOTCH2NLC presented with prominent cognitive impairment, which might be an important
symptom of differential diagnosis between MSA and NIID
before performing a genetic test.
Previous studies demonstrated that DWI high signals
along the corticomedullary junction and remarkable diffuse T2 high-intensity signals of the cerebral white matter
were characteristic findings in patients with NIID.6,13
However, a recent study revealed that only about 37.5% of
affected familial individuals presented with the classical
NIID radiological findings of linear DWI and severe white
matter hyperintensity.3 In contrast, MRI studies showing
white matter lesions typical of multiple sclerosis other than
those commonly seen in this age group are exclusionary
red flag in the Gilman criteria for MSA.9 Although 34.2%
of MSA patients had white matter hyperintensities in our
study, the white matter lesions usually distributed anterior
and posterior horns of lateral ventricle, which appeared to
be nonspecific and commonly observed in older patients
ascribed to small vessel disease. In this study, only one
patient had mild hyperintense linear lesions in the corticomedullary junction in DWI, four other patients with
GGC expansion had white matter hyperintensities,
although the white matter lesions were also located at
periventricular areas, and might be unrelated to the GGC
expansion. Therefore, the NIID patients in the early stage

may have been diagnosed as MSA because they did not
have typical radiological features of NIID. When patients
with MSA showed white matter damage, a differential
diagnosis of NIID should be considered.
MSA can be difficult to differentiate from some neurodegenerative disorders such as Parkinson’s disease,
spinocerebellar ataxia, and fragile X-associated tremor
ataxia syndrome (FXTAS).14,23 Therefore, a definite diagnosis of MSA only can be achieved by pathological
autopsy characterized with the loss of neural cells in the
central nervous system and by the presence of glial cytoplasmic inclusions in oligodendrocytes throughout the
white matter.20 As the brains of MSA patients, NIID
brains also include multiple ubiquitin- and p62-positive
inclusions.24 However, the inclusions of MSA should be
in oligodendrocytes and contain alpha-synuclein as a
major component, while our study revealed that the
inclusions from skin biopsy appeared to be exclusively
intranuclear and synuclein negative, rendering a diagnosis
of MSA doubtfully. Nevertheless, skin biopsy for alphasynuclein appears to have higher sensitivity when
acquired in the neck and upper limbs. The lack of alphasynuclein in the lower leg sample does completely not
exclude superimposed alpha-synucleinopathy.
Recent studies revealed a broadened clinical spectrum
of adult-onset NIID. GGC repeat expansion was not
only identified in typical adult- or juvenile-onset NIID
patients4 but also observed in Alzheimer disease (AD),3
Parkinson disease (PD),3 adult leukoencephalopathy,25
and essential tremor (ET),26 implicating that GGC
repeat expansions in the NOTCH2NLC gene could
partly contribute to the pathological process of multiple
neurodegenerative diseases, including MSA, AD, PD,
ET, and leukoencephalopathy. Therefore, we also agree
to define a term NIID-related disorders (NIIDRD),3
which include NIID and other related neurodegenerative
diseases caused by the GGC repeat expansion, although
it might be a misdiagnosis in nature.
In summary, adult-onset NIID should be taken into
account for differential diagnosis of MSA. 2.6% of
patients with clinically diagnosed MSA had GGC repeat
expansions in the 50 UTR of the NOTCH2NLC gene. To
our knowledge, GGC repeat expansions of the
NOTCH2NLC gene have not been observed previously in
MSA patients. Whether this possible association holds
true for a larger number of MSA patients, especially in
pathologically proven MSA, remains to be determined.
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